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for a randomized controlled study
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Abstract
Background: Postoperative recovery after live donor nephrectomy is largely determined by the consequences of
postoperative pain and analgesia consumptions. The use of deep neuromuscular blockade has been shown
to reduce postoperative pain scores after laparoscopic surgery. In this study, we will investigate whether deep
neuromuscular blockade also improves the early quality of recovery after live donor nephrectomy.
Methods: The RELAX-study is a phase IV, multicenter, double-blinded, randomized controlled trial, in which
96 patients, scheduled for living donor nephrectomy, will be randomized into two groups: one with deep
and one with moderate neuromuscular blockade. Deep neuromuscular blockade is defined as a post-tetanic
count of 1–2. Our primary outcome measurement will be the Quality of Recovery-40 questionnaire (overall
score) at 24 h after extubation.
Discussion: This study is, to our knowledge, the first randomized study to assess the effectiveness of deep
neuromuscular blockade during laparoscopic donor nephrectomy in enhancing postoperative recovery. The
study findings may also be applicable for other laparoscopic procedures.
Trial registration: clinicaltrials.gov, NCT02838134. Registered on 29 June 2016.
Keywords: Deep neuromuscular block, Early quality of recovery, Laparoscopic donor nephrectomy,
Randomized controlled trial, Rocuronium
Background
As patients with end-stage kidney disease and society
both benefit tremendously from living kidney donors,
their safety and wellbeing are highly important objectives
in living kidney donation. A systematic review of the
Cochrane collaboration by Wilson et al. has shown that
laparoscopic donor nephrectomy is associated with re-
duced analgesia use, shorter hospital stay, and faster
return to normal physical functioning, when compared
with open donor nephrectomy [1]. Nowadays, the lap-
aroscopic technique has become the gold standard in
procuring live donor kidneys.
Advances in minimally invasive surgery for live kidney
donors have led to the development of new techniques
(i.e. laparoendoscopic single-site donor nephrectomy, or
hand-assisted or robotic-assisted donor nephrectomies).
Nevertheless, there is no evidence of superiority of these
techniques as compared with standard laparoscopic
donor nephrectomy [2–6].
Postoperative recovery is largely determined by the
consequences of postoperative pain and analgesia
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consumption. In a previous pilot study by our group, low-
pressure pneumoperitoneum (7 mmHg) during laparo-
scopic donor nephrectomy reduced postoperative pain
scores, compared with standard pressure pneumoperito-
neum [7]. This finding is in agreement with a meta-analysis
showing that the use of low-pressure pneumoperitoneum
provides a clinically relevant reduction in postoperative
pain scores after laparoscopic surgery [8]. To investigate
whether the use of low-pressure pneumoperitoneum
facilitated by profound muscle relaxation improves not only
postoperative pain but also the early quality of recovery, we
performed a blinded randomized controlled trial in
patients undergoing laparoscopic donor nephrectomy ([9],
Ozdemir-van Brunschot DM, et al.: Low pressure pneumo-
peritoneum facilitated by deep neuromuscular blockade
during laparoscopic donor nephrectomy is associated with
reduced length of hospital stay, submitted). Results from
this study showed that the use of low-pressure pneumo-
peritoneum did not reduce pain scores nor improve the
quality of recovery (Ozdemir-van Brunschot DM, et al.:
Low pressure pneumoperitoneum facilitated by deep
neuromuscular blockade during laparoscopic donor neph-
rectomy is associated with reduced length of hospital stay,
submitted). A possible explanation for this finding may be
that the use of a deep neuromuscular blockade reduces
pneumoperitoneum-related pain scores by increasing the
compliance of the abdominal wall musculature. As deep
neuromuscular blockade was applied in both arms of the
study, this may have abated the analgesic effects of low-
pressure pneumoperitoneum. Therefore, we hypothesize
that the use of deep neuromuscular blockade during stand-
ard pressure laparoscopic donor nephrectomy improves the
early quality of recovery after laparoscopic donor nephrec-
tomy by reducing postoperative pain scores or analgesic
consumption.
Methods/Design
This multicenter, double-blinded, randomized controlled
trial will be performed at the Radboud University Medical
Center and the Leiden University Medical Center. We aim
to assess the effectiveness of deep versus moderate neuro-
muscular blockade during laparoscopic donor nephrec-
tomy in enhancing postoperative recovery. All eligible
donors will be screened. Patients will be included after
written informed consent. See Fig. 1 for the flow chart,
Additional file 1 for the SPIRIT checklist, and Additional
file 2 for the SPIRIT figure for study protocols.
Study population
A total of 96 patients will be randomized, based on a
computer-generated list, to either deep neuromuscular
blockade (group A) or moderate neuromuscular block-
ade (group B). Stratification by center will be used. All
adult individuals (>18 years), who are scheduled for
living kidney donation are eligible for this study. Patients
are excluded if they meet one or more of the following
exclusion criteria: insufficient control of the Dutch lan-
guage to read the patient information and to fill out the
questionnaires; chronic use of analgesics or psychotropic
drugs; use of nonsteroidal anti-inflammatory drugs <5 days
before surgery; morbid obesity (body mass index > 35 kg/m2);
known or suspect allergy to rocuronium or sugammadex;
neuromuscular disease; indication of rapid sequence in-
duction; deficiency of vitamin K-dependent clotting fac-
tors, coagulopathy or use of coumarin derivatives because
of an increased risk of bleeding when combined with
sugammadex; or peri-operative use of fusidic acid or flu-
cloxacillin because of an interaction with sugammadex.
Study protocol
Before the surgeons arrive at the operation room, all
study medications are prepared by the anesthesiologist
or the anesthesiologist’s assistant, after opening the en-
velope containing the allocation of treatment. Surgeons,
scrub nurses, and the research physician are blinded for
group allocation. Covering of the neuromuscular moni-
toring equipment, nerve stimulator and computer behind
sterile drapes ensures this. The attending anesthetic
staff in the operating room are not blinded as the
anesthesiologist has to respond adequately to the neuro-
muscular monitoring to maintain adequate neuromuscu-
lar blockade according to the allocation of treatment.
Neuromuscular function will be monitored in a stan-
dardized fashion using an acceleromyograph at the wrist
(train-of-four watch SX, MIPM GmbH). To calibrate the
train-of-four watch, first a tetanic ulnar nerve stimulus
(50 Hz for 5 s) will be administered. Thereafter, the
train-of-four watch will be calibrated, followed by three
measurements to ensure that the train-of-four ratio differs
by less than 5%. If the train-of-four ratio differs by more
than 5%, the train-of-four watch will be recalibrated. The
post-tetanic count is obtained by counting 1 Hz twitches
3 s after 5 s of 50 Hz tetany. The post-tetanic count is
used to assess the level of the deep neuromuscular
blockade and to give an approximate time until the re-
turn of response to single twitches.
Anesthesia will be induced with remifentanil 1.0 μg/kg,
propofol 1–2 mg/kg and rocuronium (intubation dose
0.6 mg/kg). Anesthesia is maintained with propofol aimed
at a bispectral index score between 45 and 55; remifentanil
administration will be at the discretion of the attending
anesthesiologist. Tracheal intubation is performed 2 min
after administration of 0.6 mg/kg rocuronium in both
groups. For a body mass index > 30 kg/m2, the dose of
rocuronium will be adjusted taking into account ideal
body weight. We will use pressure-regulated volume-
controlled ventilation through an endotracheal tube with
a mixture of oxygen in air with 5 cm H2O positive end-
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expiratory pressure and tidal volume between 6 and
8 ml/kg. Minute ventilation is adjusted to main end-
tidal carbon dioxide between 31 and 43 mmHg by
changing respiratory rate during surgery. A nasogas-
tric tube will be inserted for gastric decompression
and will be removed before the end of the surgery.
The core temperature will be measured continuously,
with the aim at maintaining it at 36–37 °C.
In group A (deep neuromuscular blockade), infusion
of rocuronium (0.3 to 0.4 mg/kg) is started and titrated
towards post-tetanic count 1–2. In group B (moderate
neuromuscular blockade), no additional rocuronium is
administered after tracheal intubation and neuromuscu-
lar function will be allowed to recover spontaneously.
All laparoscopic procedures will be performed by two
surgeons with at least one experienced transplant sur-
geon (>30 laparoscopic donor nephrectomies). The pri-
mary surgeon assesses Leiden surgical space conditions
using the Leiden surgical rating scale according to
Martini et al. [10] (see Table 1) after introduction of tro-
cars, and then every 15 min. If surgical conditions are
insufficient (surgical rating scale 1 or 2), the surgeon
only decides to convert to a higher intra-abdominal pres-
sure or an open- or hand-assisted procedure, if the safety
of the patient is compromised. In case of insufficient sur-
gical conditions due to (severe) muscle contractions (sur-
gical rating scale 1 or 2), the protocol allows a 0.6 mg/kg
bolus of rocuronium. Blood loss will be compensated with
Fig. 1 Flow chart. IAP, intra-abdominal pressure; LDN, live donor nephrectomy; NMB, neuromuscular blockade; NSAID, nonsteroidal anti-inflammatory
drug; SRS, surgical rating scale
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colloid solution; for 100 ml blood loss, 120 ml colloid so-
lution is given. Surgical wounds will be locally infiltrated
with 10 mL ropivacaine and the use of drains is avoided.
After skin closure, the neuromuscular blockade is reversed
with sugammadex, at a dose of 4 mg/kg in group A and a
dose of 2 mg/kg in group B. When the patients have a
stable train-of-four ratio of more than 0.9 for 2 min and
are fully awake, extubation is performed. The blinded re-
search physician will register intra-operative parameters
(e.g. Leiden surgical rating scale score, blood loss, warm
ischemia time, conversion to open or hand-assisted donor
nephrectomy and intra-operative complications).
Postoperative pain and nausea will be assessed at 1, 6, 24,
and 48 h after extubation. Postoperative pain management
is achieved by acetaminophen (total 4000 mg daily) and
either patient-controlled analgesia (morphine, 1 mg mor-
phine per bolus, lock-out 6 min) or intramuscular mor-
phine, at the patient’s request. On day 1, patient-controlled
analgesia will be replaced with oral analgesics. If there is
postoperative nausea or vomiting, 4 mg intravenous ondan-
setron (maximum 12 mg/day) will be administered or, as
an alternative, 10 mg intravenous metoclopramide (max-
imum 30 mg/day). On day 1, the urine catheter will be re-
moved and a normal diet and mobilization will be started
immediately. The research physician will assess all postop-
erative pain scores and perform daily evaluation with regard
to the use of analgesics and anti-emetics and urine output.
Discharge criteria will be evaluated daily. Discharge criteria
are adequate pain control with oral medication, passage of
flatus or defecation, intake of solid food tolerated, patient is
mobilized and independent and patient accepts discharge.
If hospitalization is prolonged for non-medical reasons (e.g.
social reasons) the ‘virtual’ discharge date is listed.
Outcome measures
The primary outcome measure is the total score of the
Quality of Recovery-40 Questionnaire (QoR-40) at 24 h after
extubation. This questionnaire has 40 questions measuring
five dimensions: patient support, comfort, emotions, phys-
ical independence, and pain. Each item is rated on a scale of
1 to 5, giving a minimum score of 40 and a maximum score
of 200 [11]. The QoR-40 is one of the most thoroughly vali-
dated assessment tools available for measuring a patient’s
self-assessed quality of recovery after surgery [12].
The secondary outcome measures are: intra-operative
parameters (e.g. surgical conditions (see Table 1), oper-
ation time, length of pneumoperitoneum, warm ischemia
time, estimated blood loss, conversion to higher intra-
abdominal pressure, hand-assisted or open donor neph-
rectomy, intra-operative complications), the total QoR-40
score at 48 h after extubation, postoperative pain (compo-
nents of pain scores); postoperative nausea and vomit-
ing (numeric rating scale), cumulative use of analgesics
and anti-emetics, time to reach discharge criteria, re-
admissions and postoperative complications. Follow-up
will be performed after 30 and 60 days, evaluating the
pain scores, complications and administering the Work
and Healthcare Questionnaire.
The extent of pain, nausea and vomiting and cumula-
tive analgesia and anti-emetics use will be assessed at 1,
6, 24, and 48 h. Complications and discharge criteria will
be evaluated daily. A complete overview of the time
schedule is given in Table 2.
Adverse events and reactions
Since the use of a deep neuromuscular blockade with a
standard insufflations pressure improves the quality of the
Table 2 Overview of variables and time-points
−18 h 1 h 6 h 24 h 48 h 30 days
Quality of Recovery-40 questionnaire x x x
Components of pain x x x x x x
Analgesia use x x x x x
Discharge criteria x x x
Evaluation of complications x x x
Table 1 Assessment of Leiden surgical space conditions (Leiden surgical rating scale) [10]
Scale Description
1 Extremely poor conditions The surgeon is unable to work because of coughing or the inability to obtain a visible laparoscopic field
because of inadequate muscle relaxation.
2 Poor conditions There is a visible laparoscopic field, but the surgeon is severely hampered by inadequate muscle relaxation
with continuous muscle contractions, movements or both with the hazard of tissue damage.
3 Acceptable conditions There is a wide visible laparoscopic field but muscle contractions, movements or both occur regularly,
causing some interference with the surgeon’s work.
4 Good conditions There is a wide laparoscopic field with sporadic muscle contractions or movements, or both.
5 Optimal conditions There is a wide visible laparoscopic working field without movement or contractions.
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surgical field, there are no risks related to the surgery [10].
Preliminary data from our recently performed Leopard-3
study show that the mean surgical rating scale was signifi-
cantly better during deep neuromuscular blockade with
less opiate consumption (Ozdemir-van Brunschot DM,
et al.: Deep neuromuscular blockade improves surgical
conditions during low-pressure pneumoperitoneum
laparoscopic donor nephrectomy, submitted). A deep
neuromuscular block can be achieved by higher doses of
rocuronium as compared with the routine intubation
dose. To overcome the extended effects of deep neuro-
muscular blockade that might lead to airway obstruction,
hypoxia, pneumonia, or atelectasis, sugammadex is
administered to antagonize the effects of rocuronium.
Sugammadex can be administered safely to patients, with-
out dose adjustments for young, elderly, or obese patients
and can also be safely administered to patients with sub-
optimal renal function. Patients will only be extubated
when the train-of-four is >90%. Furthermore, patients will
remain in the post-anesthesia care unit for 2 h, to ensure
adequate neuromuscular function.
Sample size calculation
A sample size of 48 patients per group is needed to pro-
vide 90% power to detect a 10-point difference in the
quality of recovery score at 1 day after extubation (alpha,
5%). Based on our previous studies, the standard devi-
ation is 15 points [9].
It is generally assumed that a clinically relevant im-
provement in quality of recovery is represented by a
point 10 difference in QoR-40 score, because a 10-point
difference represents a 15% improvement in the quality
of recovery based on previously reported values on the
mean and range of the QoR-40 score in patients after
anesthesia and surgery [12–17].
Data management and monitoring
Subjects will be coded by a numeric code to create an an-
onymous dataset. A Castor database will be developed
and used for data management. Monitoring will be con-
ducted in accordance with negligible risk monitoring
guidelines of the Dutch Federation of Academic Medical
Centers. The investigator will submit a summary of the
progress of the trial to the accredited medical research
ethics committee once a year. Information will be pro-
vided on the date of inclusion of the first subject, numbers
of subjects included and numbers of subjects who have
completed the trial, serious adverse events, serious adverse
reactions, other problems and amendments.
Statistical methods
For the primary analysis, groups A and B will be com-
pared with regard to the primary end-point (QoR-40
score at day 1). Analysis of covariance (ANCOVA) will
be used to compare groups and to adjust for co-
variates i.e. age, sex, number of arteries, and side of
nephrectomy. Statistical significance will be considered for
P < 0.05. All analyses will be performed on an intention-
to-treat basis. When a significant number of patients
(>10%) allocated to a moderate neuromuscular blockade
have received deep relaxation due to additional boluses of
rocuronium (post-tetanic count ≤ 2) for the duration of
>50% of the operation time, both an intention-to-treat
and a per-protocol analysis will be performed. Statistical
analyses will be performed using SPSS 22.0 (SPSS Inc.,
Chicago, IL, USA).
Discussion
Laparoscopic donor nephrectomy has become the gold
standard in procuring live donor kidneys. Laparoscopic
donor nephrectomy is associated with reduced anal-
gesia use, shorter hospital stay, and faster return to nor-
mal physical functioning, as compared with open donor
nephrectomy. Originally, enhanced recovery programs
have been developed in Europe to address prolonged
length of stay after colorectal resections [18]. The en-
hanced recovery program care pathways reduce surgical
stress, maintain postoperative physiological function,
and enhance mobilization after surgery. It has been
shown that enhanced recovery programs within laparo-
scopic surgeries decrease the length of stay, with
equivalent morbidity, mortality, and readmission rates
[19]. Likewise, Waits et al. showed that implementation
of an enhanced recovery program in living donor neph-
rectomy improves length of stay and narcotic use, as
compared with a standard care protocol [20]. In our
previous trials, we studied the effect of low-pressure
pneumoperitoneum during laparoscopic donor neph-
rectomy on postoperative pain scores and the early
quality of recovery. Live kidney donors allocated to the
low-pressure group showed lower postoperative pain
scores.
The use of a deep neuromuscular block could be a new
element of an enhanced recovery program in patients
undergoing laparoscopic surgery. Our primary hypothesis
is that the use of deep neuromuscular blockade during
laparoscopic donor nephrectomy improves the early
quality of recovery of living donor kidney donors. Deep
neuromuscular blockade may increase relaxation of the
abdominal wall musculature; this may reduce stretch-
related abdominal pain scores after laparoscopy. Some
evidence exists that the use of a deep neuromuscular
blockade reduces pain scores independently of the insuf-
flation pressure. For example, Martini et al. showed that
deep neuromuscular blockade improves surgical condi-
tions, with reduced postoperative pain scores after laparo-
scopic surgery [10]. Moreover, preliminary data of our
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recently performed study (Ozdemir-van Brunschot DM,
et al.: Deep neuromuscular blockade improves surgical
conditions during low-pressure pneumoperitoneum laparo-
scopic donor nephrectomy, submitted) show that the mean
surgical rating scale was significantly better during deep
neuromuscular blockade, with less opiate consumption.
The main strength of our study is that this is the
first randomized controlled trial designed to study the
effect of deep neuromuscular blockade on the early
quality of recovery. The QoR questionnaire is a thor-
oughly validated assessment tool to measure a pa-
tient’s self-assessed quality of recovery after surgery
[12]. Improvement in the early quality of recovery in-
creases patients’ comfort and may contribute to earlier
eating and mobilization. According to the principles of
enhanced recovery, this may lead to a reduction in hos-
pital stay. Another strength is that we study a highly
homogeneous population of relatively healthy kidney
donors. This may reduce bias, as similar baseline char-
acteristics in both groups decrease the risk of con-
founding factors. Finally, it is reasonable to assume that
results from this study also hold for many other laparo-
scopic procedures.
A limitation of this study is that the minimal clinically
important difference of the quality of recovery score is
still under debate. We performed a power calculation
based on the assumption that the minimal clinically im-
portant difference is 10 points. Recently Myles et al.
published data [21], in which they estimate a 6.3 point
difference as the minimal clinically important difference
for the QoR-40 score. This estimate was based on tri-
angulation of distribution- and anchor based calculations
of the minimal clinically important difference. However,
it is important to note that the study population in-
cluded a broad range of surgical procedures, varying in
extent as well as type of surgery. In our view, a 10-point
difference in the QoR-40 score would be more appropriate
than a 6.3 difference, as the gain in quality of recovery has
to outweigh the additional costs and expertise required for
the application of deep neuromuscular blockade.
In conclusion, we aim to investigate the effects of deep
neuromuscular blockade on the early quality of recovery
in laparoscopic donor nephrectomy. Our hypothesis is
that the use of deep neuromuscular blockade will lead to
enhanced recovery after surgery.
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Recruiting patients.
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